s pneumoniae atcc 49619 Search Results


99
ATCC atcc 49619 staphylococcus pneumoniae
Atcc 49619 Staphylococcus Pneumoniae, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/s+pneumoniae+atcc+49619/10__1128_slash_jcm__02155___15-40-183-183?v=ATCC
Average 99 stars, based on 1 article reviews
atcc 49619 staphylococcus pneumoniae - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier

99
ATCC s pneumoniae
Patient characteristics
S Pneumoniae, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/s+pneumoniae+atcc+49619/pmc07089193-102-5-7?v=ATCC
Average 99 stars, based on 1 article reviews
s pneumoniae - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier

92
ATCC gram positive
Patient characteristics
Gram Positive, supplied by ATCC, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/s+pneumoniae+atcc+49619/pmc05986684-51-1-8?v=ATCC
Average 92 stars, based on 1 article reviews
gram positive - by Bioz Stars, 2026-08
92/100 stars
  Buy from Supplier

90
ATCC s pneumoniae cdc
In vitro susceptibilities of the strains tested to gatifloxacin, penicillin, methicillin, and ciprofloxacin
S Pneumoniae Cdc, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/s+pneumoniae+atcc+49619/pmc00127205-283-96-82?v=ATCC
Average 90 stars, based on 1 article reviews
s pneumoniae cdc - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

99
ATCC clsi quality control organisms
In vitro susceptibilities of the strains tested to gatifloxacin, penicillin, methicillin, and ciprofloxacin
Clsi Quality Control Organisms, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/s+pneumoniae+atcc+49619/pmc05404553-57-11-18?v=ATCC
Average 99 stars, based on 1 article reviews
clsi quality control organisms - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier

96
ATCC streptococcus pneumoniae
In vitro susceptibilities of the strains tested to gatifloxacin, penicillin, methicillin, and ciprofloxacin
Streptococcus Pneumoniae, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/s+pneumoniae+atcc+49619/10__1128_slash_jcm__00861___07-12-97-99?v=ATCC
Average 96 stars, based on 1 article reviews
streptococcus pneumoniae - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

99
ATCC streptococcus pneumoniae atcc 49619
In vitro susceptibilities of the strains tested to gatifloxacin, penicillin, methicillin, and ciprofloxacin
Streptococcus Pneumoniae Atcc 49619, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/s+pneumoniae+atcc+49619/10__1016_slash_j__sajb__2018__06__005-54-27-29?v=ATCC
Average 99 stars, based on 1 article reviews
streptococcus pneumoniae atcc 49619 - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier

94
ATCC s pneumoniae atcc
In vitro susceptibilities of the strains tested to gatifloxacin, penicillin, methicillin, and ciprofloxacin
S Pneumoniae Atcc, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/s+pneumoniae+atcc+49619/pm37084337__sb3c00055_si_001-332-180-182?v=ATCC
Average 94 stars, based on 1 article reviews
s pneumoniae atcc - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

99
ATCC quality control organisms
In vitro susceptibilities of the strains tested to gatifloxacin, penicillin, methicillin, and ciprofloxacin
Quality Control Organisms, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/s+pneumoniae+atcc+49619/pm11152427-42-27-32?v=ATCC
Average 99 stars, based on 1 article reviews
quality control organisms - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier

96
ATCC strepto coccus pneumoniae
In vitro susceptibilities of the strains tested to gatifloxacin, penicillin, methicillin, and ciprofloxacin
Strepto Coccus Pneumoniae, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/s+pneumoniae+atcc+49619/10__4236_slash_ojms__2016__62028-29-58-61?v=ATCC
Average 96 stars, based on 1 article reviews
strepto coccus pneumoniae - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

90
ATCC susceptible haemophilus influenzae nctc 11931 susceptible streptococcus pneumoniae nctc 12977
In vitro susceptibilities of the strains tested to gatifloxacin, penicillin, methicillin, and ciprofloxacin
Susceptible Haemophilus Influenzae Nctc 11931 Susceptible Streptococcus Pneumoniae Nctc 12977, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/s+pneumoniae+atcc+49619/pm19587067-66-59-69?v=ATCC
Average 90 stars, based on 1 article reviews
susceptible haemophilus influenzae nctc 11931 susceptible streptococcus pneumoniae nctc 12977 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

97
ATCC reference strains
In vitro susceptibilities of the strains tested to gatifloxacin, penicillin, methicillin, and ciprofloxacin
Reference Strains, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/s+pneumoniae+atcc+49619/10__9734_slash_bji_slash_2022_slash_v26i6665-8-14-18?v=ATCC
Average 97 stars, based on 1 article reviews
reference strains - by Bioz Stars, 2026-08
97/100 stars
  Buy from Supplier

Image Search Results


Patient characteristics

Journal: Molecular Biology Reports

Article Title: Feasibility of a quantitative polymerase chain reaction assay for diagnosing pneumococcal pneumonia using oropharyngeal swabs

doi: 10.1007/s11033-018-4558-0

Figure Lengend Snippet: Patient characteristics

Article Snippet: The calculated average concentration of S. pneumoniae (ATCC 49619) was used to assess a standard curve.

Techniques:

In vitro susceptibilities of the strains tested to gatifloxacin, penicillin, methicillin, and ciprofloxacin

Journal:

Article Title: Pharmacodynamics of the New Fluoroquinolone Gatifloxacin in Murine Thigh and Lung Infection Models

doi: 10.1128/AAC.46.6.1665-1670.2002

Figure Lengend Snippet: In vitro susceptibilities of the strains tested to gatifloxacin, penicillin, methicillin, and ciprofloxacin

Article Snippet: The magnitudes of the parameter needed to achieve a static effect were 1.3- to 2.2-fold lower in the nonneutropenic infection model. table ft1 table-wrap mode="anchored" t5 TABLE 3. caption a7 Organism MIC (μg/ml) 24-h AUC/MIC ratio required for: Static effect 1 log 10 kill 2 log 10 killing S. pneumoniae CDC 145 0.25 37.0 45.8 56.1 S. pneumoniae CDC 146 0.25 54.8 66.7 81.4 S. pneumoniae CDC 673 0.25 53.6 64.4 78.4 S. pneumoniae CDC 1020 0.50 57.6 81.1 114 S. pneumoniae ATCC 10813 0.25 72.4 107.7 160.0 S. pneumoniae ATCC 49619 0.25 40.0 45.2 50.9 S. pneumoniae CDC 1396 0.50 18.4 24.9 33.8 S. pneumoniae MNO-418 8.0 23.1 33.4 45.3 S. pneumoniae T6-2668 2.0 51.3 80.5 128 Mean ± SD 52.0 ± 20.3 61.1 ± 26.4 83.1 ± 42.6 S. aureus ATCC 25923 0.12 27.2 47.8 76.5 S. aureus ATCC 33591 0.12 45.6 74.2 113 S. aureus ATCC 29213 0.12 29.7 54.5 90.9 S. aureus ATCC 6538p 0.06 43.2 131 507 Mean ± SD 36.4 ± 9.3 76.9 ± 37.8 197 ± 207 E. coli ATCC 25922 0.015 54.1 86.5 133 K. pneumoniae ATCC 43816 (thigh model, neutropenic mice) 0.06 69.7 129 235 K. pneumoniae ATCC 43816 (thigh model, nonneutropenic mice) 0.06 32.2 62.2 165 a K. pneumoniae ATCC 43816 (lung model, neutropenic mice) 0.06 55.9 96.1 153 K. pneumoniae ATCC 43816 (lung model, nonneutropenic mice) 0.06 43.2 63.2 91 a E. cloacae L2249 0.12 16.4 32.8 64.8 E. cloacae L4567 0.12 27.3 57.4 132 P. aeruginosa ATCC 27853 2.0 23.6 31.2 41.0 Mean ± SD 41.2 ± 21.5 72.2 ± 38.6 126 ± 68.8 Open in a separate window a Datum not included in calculation of the mean.

Techniques: In Vitro

In vivo PAEs of gatifloxacin after administration of single doses of 8 and 32 mg/kg against S. pneumoniae ATCC 10813 (A) and S. aureus ATCC 6538p (B). Each symbol represents the mean ± standard deviation for two mice. The widths of the bars represent the duration of time that levels in serum exceeded the MIC for the infecting pathogen.

Journal:

Article Title: Pharmacodynamics of the New Fluoroquinolone Gatifloxacin in Murine Thigh and Lung Infection Models

doi: 10.1128/AAC.46.6.1665-1670.2002

Figure Lengend Snippet: In vivo PAEs of gatifloxacin after administration of single doses of 8 and 32 mg/kg against S. pneumoniae ATCC 10813 (A) and S. aureus ATCC 6538p (B). Each symbol represents the mean ± standard deviation for two mice. The widths of the bars represent the duration of time that levels in serum exceeded the MIC for the infecting pathogen.

Article Snippet: The magnitudes of the parameter needed to achieve a static effect were 1.3- to 2.2-fold lower in the nonneutropenic infection model. table ft1 table-wrap mode="anchored" t5 TABLE 3. caption a7 Organism MIC (μg/ml) 24-h AUC/MIC ratio required for: Static effect 1 log 10 kill 2 log 10 killing S. pneumoniae CDC 145 0.25 37.0 45.8 56.1 S. pneumoniae CDC 146 0.25 54.8 66.7 81.4 S. pneumoniae CDC 673 0.25 53.6 64.4 78.4 S. pneumoniae CDC 1020 0.50 57.6 81.1 114 S. pneumoniae ATCC 10813 0.25 72.4 107.7 160.0 S. pneumoniae ATCC 49619 0.25 40.0 45.2 50.9 S. pneumoniae CDC 1396 0.50 18.4 24.9 33.8 S. pneumoniae MNO-418 8.0 23.1 33.4 45.3 S. pneumoniae T6-2668 2.0 51.3 80.5 128 Mean ± SD 52.0 ± 20.3 61.1 ± 26.4 83.1 ± 42.6 S. aureus ATCC 25923 0.12 27.2 47.8 76.5 S. aureus ATCC 33591 0.12 45.6 74.2 113 S. aureus ATCC 29213 0.12 29.7 54.5 90.9 S. aureus ATCC 6538p 0.06 43.2 131 507 Mean ± SD 36.4 ± 9.3 76.9 ± 37.8 197 ± 207 E. coli ATCC 25922 0.015 54.1 86.5 133 K. pneumoniae ATCC 43816 (thigh model, neutropenic mice) 0.06 69.7 129 235 K. pneumoniae ATCC 43816 (thigh model, nonneutropenic mice) 0.06 32.2 62.2 165 a K. pneumoniae ATCC 43816 (lung model, neutropenic mice) 0.06 55.9 96.1 153 K. pneumoniae ATCC 43816 (lung model, nonneutropenic mice) 0.06 43.2 63.2 91 a E. cloacae L2249 0.12 16.4 32.8 64.8 E. cloacae L4567 0.12 27.3 57.4 132 P. aeruginosa ATCC 27853 2.0 23.6 31.2 41.0 Mean ± SD 41.2 ± 21.5 72.2 ± 38.6 126 ± 68.8 Open in a separate window a Datum not included in calculation of the mean.

Techniques: In Vivo, Standard Deviation

Relationships of the gatifloxacin 24-h AUC/MIC (A), peak level/MIC (B), and T>MIC (C) for S. pneumoniae ATCC 10813 with the log10 numbers of CFU per thigh after 24 h of therapy. Each symbol represents the mean for two thighs per mouse. The horizontal dashed lines represent the organism burden at the start of therapy.

Journal:

Article Title: Pharmacodynamics of the New Fluoroquinolone Gatifloxacin in Murine Thigh and Lung Infection Models

doi: 10.1128/AAC.46.6.1665-1670.2002

Figure Lengend Snippet: Relationships of the gatifloxacin 24-h AUC/MIC (A), peak level/MIC (B), and T>MIC (C) for S. pneumoniae ATCC 10813 with the log10 numbers of CFU per thigh after 24 h of therapy. Each symbol represents the mean for two thighs per mouse. The horizontal dashed lines represent the organism burden at the start of therapy.

Article Snippet: The magnitudes of the parameter needed to achieve a static effect were 1.3- to 2.2-fold lower in the nonneutropenic infection model. table ft1 table-wrap mode="anchored" t5 TABLE 3. caption a7 Organism MIC (μg/ml) 24-h AUC/MIC ratio required for: Static effect 1 log 10 kill 2 log 10 killing S. pneumoniae CDC 145 0.25 37.0 45.8 56.1 S. pneumoniae CDC 146 0.25 54.8 66.7 81.4 S. pneumoniae CDC 673 0.25 53.6 64.4 78.4 S. pneumoniae CDC 1020 0.50 57.6 81.1 114 S. pneumoniae ATCC 10813 0.25 72.4 107.7 160.0 S. pneumoniae ATCC 49619 0.25 40.0 45.2 50.9 S. pneumoniae CDC 1396 0.50 18.4 24.9 33.8 S. pneumoniae MNO-418 8.0 23.1 33.4 45.3 S. pneumoniae T6-2668 2.0 51.3 80.5 128 Mean ± SD 52.0 ± 20.3 61.1 ± 26.4 83.1 ± 42.6 S. aureus ATCC 25923 0.12 27.2 47.8 76.5 S. aureus ATCC 33591 0.12 45.6 74.2 113 S. aureus ATCC 29213 0.12 29.7 54.5 90.9 S. aureus ATCC 6538p 0.06 43.2 131 507 Mean ± SD 36.4 ± 9.3 76.9 ± 37.8 197 ± 207 E. coli ATCC 25922 0.015 54.1 86.5 133 K. pneumoniae ATCC 43816 (thigh model, neutropenic mice) 0.06 69.7 129 235 K. pneumoniae ATCC 43816 (thigh model, nonneutropenic mice) 0.06 32.2 62.2 165 a K. pneumoniae ATCC 43816 (lung model, neutropenic mice) 0.06 55.9 96.1 153 K. pneumoniae ATCC 43816 (lung model, nonneutropenic mice) 0.06 43.2 63.2 91 a E. cloacae L2249 0.12 16.4 32.8 64.8 E. cloacae L4567 0.12 27.3 57.4 132 P. aeruginosa ATCC 27853 2.0 23.6 31.2 41.0 Mean ± SD 41.2 ± 21.5 72.2 ± 38.6 126 ± 68.8 Open in a separate window a Datum not included in calculation of the mean.

Techniques:

Relationship between gatifloxacin dosing interval and bacteriostatic efficacy

Journal:

Article Title: Pharmacodynamics of the New Fluoroquinolone Gatifloxacin in Murine Thigh and Lung Infection Models

doi: 10.1128/AAC.46.6.1665-1670.2002

Figure Lengend Snippet: Relationship between gatifloxacin dosing interval and bacteriostatic efficacy

Article Snippet: The magnitudes of the parameter needed to achieve a static effect were 1.3- to 2.2-fold lower in the nonneutropenic infection model. table ft1 table-wrap mode="anchored" t5 TABLE 3. caption a7 Organism MIC (μg/ml) 24-h AUC/MIC ratio required for: Static effect 1 log 10 kill 2 log 10 killing S. pneumoniae CDC 145 0.25 37.0 45.8 56.1 S. pneumoniae CDC 146 0.25 54.8 66.7 81.4 S. pneumoniae CDC 673 0.25 53.6 64.4 78.4 S. pneumoniae CDC 1020 0.50 57.6 81.1 114 S. pneumoniae ATCC 10813 0.25 72.4 107.7 160.0 S. pneumoniae ATCC 49619 0.25 40.0 45.2 50.9 S. pneumoniae CDC 1396 0.50 18.4 24.9 33.8 S. pneumoniae MNO-418 8.0 23.1 33.4 45.3 S. pneumoniae T6-2668 2.0 51.3 80.5 128 Mean ± SD 52.0 ± 20.3 61.1 ± 26.4 83.1 ± 42.6 S. aureus ATCC 25923 0.12 27.2 47.8 76.5 S. aureus ATCC 33591 0.12 45.6 74.2 113 S. aureus ATCC 29213 0.12 29.7 54.5 90.9 S. aureus ATCC 6538p 0.06 43.2 131 507 Mean ± SD 36.4 ± 9.3 76.9 ± 37.8 197 ± 207 E. coli ATCC 25922 0.015 54.1 86.5 133 K. pneumoniae ATCC 43816 (thigh model, neutropenic mice) 0.06 69.7 129 235 K. pneumoniae ATCC 43816 (thigh model, nonneutropenic mice) 0.06 32.2 62.2 165 a K. pneumoniae ATCC 43816 (lung model, neutropenic mice) 0.06 55.9 96.1 153 K. pneumoniae ATCC 43816 (lung model, nonneutropenic mice) 0.06 43.2 63.2 91 a E. cloacae L2249 0.12 16.4 32.8 64.8 E. cloacae L4567 0.12 27.3 57.4 132 P. aeruginosa ATCC 27853 2.0 23.6 31.2 41.0 Mean ± SD 41.2 ± 21.5 72.2 ± 38.6 126 ± 68.8 Open in a separate window a Datum not included in calculation of the mean.

Techniques:

Relationship between gatifloxacin MIC and AUC/MIC necessary to achieve a static effect and 1 log 10 and 2 log 10 killing

Journal:

Article Title: Pharmacodynamics of the New Fluoroquinolone Gatifloxacin in Murine Thigh and Lung Infection Models

doi: 10.1128/AAC.46.6.1665-1670.2002

Figure Lengend Snippet: Relationship between gatifloxacin MIC and AUC/MIC necessary to achieve a static effect and 1 log 10 and 2 log 10 killing

Article Snippet: The magnitudes of the parameter needed to achieve a static effect were 1.3- to 2.2-fold lower in the nonneutropenic infection model. table ft1 table-wrap mode="anchored" t5 TABLE 3. caption a7 Organism MIC (μg/ml) 24-h AUC/MIC ratio required for: Static effect 1 log 10 kill 2 log 10 killing S. pneumoniae CDC 145 0.25 37.0 45.8 56.1 S. pneumoniae CDC 146 0.25 54.8 66.7 81.4 S. pneumoniae CDC 673 0.25 53.6 64.4 78.4 S. pneumoniae CDC 1020 0.50 57.6 81.1 114 S. pneumoniae ATCC 10813 0.25 72.4 107.7 160.0 S. pneumoniae ATCC 49619 0.25 40.0 45.2 50.9 S. pneumoniae CDC 1396 0.50 18.4 24.9 33.8 S. pneumoniae MNO-418 8.0 23.1 33.4 45.3 S. pneumoniae T6-2668 2.0 51.3 80.5 128 Mean ± SD 52.0 ± 20.3 61.1 ± 26.4 83.1 ± 42.6 S. aureus ATCC 25923 0.12 27.2 47.8 76.5 S. aureus ATCC 33591 0.12 45.6 74.2 113 S. aureus ATCC 29213 0.12 29.7 54.5 90.9 S. aureus ATCC 6538p 0.06 43.2 131 507 Mean ± SD 36.4 ± 9.3 76.9 ± 37.8 197 ± 207 E. coli ATCC 25922 0.015 54.1 86.5 133 K. pneumoniae ATCC 43816 (thigh model, neutropenic mice) 0.06 69.7 129 235 K. pneumoniae ATCC 43816 (thigh model, nonneutropenic mice) 0.06 32.2 62.2 165 a K. pneumoniae ATCC 43816 (lung model, neutropenic mice) 0.06 55.9 96.1 153 K. pneumoniae ATCC 43816 (lung model, nonneutropenic mice) 0.06 43.2 63.2 91 a E. cloacae L2249 0.12 16.4 32.8 64.8 E. cloacae L4567 0.12 27.3 57.4 132 P. aeruginosa ATCC 27853 2.0 23.6 31.2 41.0 Mean ± SD 41.2 ± 21.5 72.2 ± 38.6 126 ± 68.8 Open in a separate window a Datum not included in calculation of the mean.

Techniques: